Table I.
AERD patients, N=28 | |
---|---|
Age (y), mean ±SE | 46 ±2.7 |
Female patients, N (%) | 18 (67) |
Race, N (%) | |
African American | 14 (50) |
Latino | 7 (25) |
White | 7 (25) |
ICS/LABA* use, N (%) | 23 (82) |
Oral corticosteroids use, N (%) | 3 (11) |
ICS/LABA – inhaled corticosteroids/long-acting beta-agonists